Data as of Dec 19
| -0.36 / -2.29%|
The 4 analysts offering 12-month price forecasts for Sangamo BioSciences Inc have a median target of 25.00, with a high estimate of 29.00 and a low estimate of 22.00. The median estimate represents a +62.76% increase from the last price of 15.36.
The current consensus among 5 polled investment analysts is to Buy stock in Sangamo BioSciences Inc. This rating has held steady since December, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.